DexCom (DXCM) Tops Q4 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
DexCom (DXCM) PT Raised to $140 at Jefferies
February 10, 2023 8:13 AM ESTJefferies analyst Matthew Taylor raised the price target on DexCom (NASDAQ: DXCM) to $140.00 (from $135.00) while maintaining a Buy rating following earnings.
The analyst commented, "DXCM reported 4Q sales of $815.2MM +20% organic, and reiterated guidance for the year. As a reminder, DXCM... More
